Active Ingredient: TOFACITINIB CITRATE
Proprietary Name: TOFACITINIB CITRATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 5MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A209829
Product Number: 001
Approval Date: Mar 13, 2023
Applicant Holder Full Name: ZYDUS PHARMACEUTICALS USA INC
Marketing Status:
Discontinued
Patent and Exclusivity Information